You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for NIGHT TIME COLD-FLU LIQUID


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NIGHT TIME COLD-FLU LIQUID

Average Pharmacy Cost for NIGHT TIME COLD-FLU LIQUID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NIGHT TIME COLD-FLU LIQUID 46122-0136-34 0.01457 ML 2025-01-22
NIGHT TIME COLD-FLU LIQUID 46122-0198-34 0.01457 ML 2025-01-22
NIGHT TIME COLD-FLU LIQUID 46122-0198-40 0.01056 ML 2025-01-22
NIGHT TIME COLD-FLU LIQUID 46122-0136-34 0.01501 ML 2024-12-18
NIGHT TIME COLD-FLU LIQUID 46122-0198-40 0.01056 ML 2024-12-18
NIGHT TIME COLD-FLU LIQUID 46122-0198-34 0.01501 ML 2024-12-18
NIGHT TIME COLD-FLU LIQUID 46122-0198-40 0.01056 ML 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Night Time Cold-Flu Liquid

Market Overview

The market for cold and flu medications, particularly nighttime relief liquids, is experiencing significant growth driven by several key factors.

Growing Demand and Revenue

The cold and flu relief market on Amazon has seen a 39% surge in revenue and a 32% increase in unit sales over the past 90 days, compared to the same period last year. This growth is largely attributed to increased consumer demand rather than price hikes, as the median price has remained relatively steady[1].

Global Market Size and Forecast

Globally, the cold and flu drugs market was valued at USD 16.85 billion in 2024 and is projected to reach USD 29.39 billion by 2031, growing at a CAGR of 7.20% from 2024 to 2031. This growth is fueled by the development of novel antiviral medicines, increased awareness of seasonal flu prevention, and the rise of telemedicine and internet pharmacies[3].

Key Players and Products

Vicks NyQuil

NyQuil Severe Cold and Flu Relief Liquid from Vicks is a leading product in this segment. It has seen a 718% increase in revenue over the past 90 days compared to the year-ago period. This product offers fast, powerful relief for multiple symptoms such as headache, fever, sore throat, minor aches and pains, sneezing, runny nose, and cough[1][2].

Market Trends

Preference for Over-the-Counter (OTC) Medications

There is a growing shift towards self-medication, with consumers increasingly opting for OTC cold and flu drugs. This trend is driven by factors like easy accessibility, affordability, and the desire to manage symptoms without visiting healthcare professionals. OTC medications dominate the market due to their ease of accessibility and wide availability without the need for a doctor’s prescription[3][4].

Demand for Combination Therapies

Consumers are seeking combination therapies that address multiple symptoms in a single dose. Products like NyQuil, which offer relief for common cold and flu symptoms such as headache, fever, and cough, are highly preferred due to their convenience and effectiveness[3].

Price Dynamics

Current Pricing

The median price for cold and flu relief products on Amazon has remained relatively steady, with a slight increase of 5% over the past 90 days. This stability suggests that price is not a significant driver of the current market growth[1].

Price Projections

Given the steady demand and the projected growth of the cold and flu drugs market, prices are likely to remain competitive. However, as the market continues to grow, there might be slight adjustments to prices due to increased production costs or changes in consumer demand. The CAGR of 7.20% from 2024 to 2031 indicates a stable and growing market, which may support moderate price increases without deterring consumer demand[3].

Regional Market Insights

North America

North America, particularly the United States, dominates the cold and flu drugs market due to the high incidence of respiratory illnesses and an advanced healthcare infrastructure. The region experiences millions of flu cases annually, creating a robust demand for cold and flu treatments[3].

Opportunities and Challenges

Opportunities

  • Social Media Expansion: Leveraging social media platforms to increase brand awareness and reach a wider audience.
  • International Expansion: Expanding product availability to international markets where demand for cold and flu medications is high.
  • Promotions and Coupons: Utilizing promotions and coupons to attract more customers and increase sales[5].

Challenges

  • Market Saturation: The market is highly competitive, with many established brands and generic alternatives.
  • Consumer Preferences: Consumers are increasingly looking for products with natural and immunity-boosting properties, which can be a challenge for traditional OTC medications[5].

Consumer Behavior and Preferences

Nighttime Relief

Consumers are particularly interested in nighttime relief products that help them get rest while alleviating cold and flu symptoms. NyQuil’s nighttime relief liquid, for example, is highly effective in providing fast relief so that consumers can sleep[2].

Holistic Healthcare Solutions

There is a growing preference for drugs with natural and immunity-boosting properties, reflecting a broader trend towards holistic healthcare solutions. This trend may influence the development of future cold and flu medications[4].

Key Takeaways

  • The cold and flu relief market is experiencing significant growth driven by increased consumer demand.
  • Nighttime relief liquids, such as NyQuil, are highly sought after for their multi-symptom relief.
  • The global market for cold and flu drugs is projected to grow at a CAGR of 7.20% from 2024 to 2031.
  • OTC medications dominate the market due to their ease of accessibility and wide availability.
  • Consumer preferences are shifting towards combination therapies and natural, immunity-boosting products.

Frequently Asked Questions (FAQs)

1. What is driving the growth in the cold and flu relief market? The growth is primarily driven by increased consumer demand, the development of novel antiviral medicines, and heightened awareness of seasonal flu prevention[1][3].

2. Which product is leading in the nighttime cold-flu relief segment? NyQuil Severe Cold and Flu Relief Liquid from Vicks is a leading product in this segment, known for its fast and powerful relief for multiple symptoms[1][2].

3. Why are consumers preferring OTC medications over prescription medications? Consumers prefer OTC medications due to their ease of accessibility, affordability, and the convenience of managing symptoms without visiting healthcare professionals[3][4].

4. What are the key trends influencing the cold and flu drugs market? Key trends include the demand for combination therapies, a growing preference for natural and immunity-boosting products, and the rise of telemedicine and internet pharmacies[3][4].

5. How is the global market for cold and flu drugs expected to grow in the coming years? The global market is projected to grow at a CAGR of 7.20% from 2024 to 2031, reaching USD 29.39 billion by 2031[3].

Cited Sources:

  1. Amazon Market Watch: Cold & Flu Season Trends & Top Sellers - Jungle Scout
  2. NyQuil™ Cough, Cold & Flu Nighttime Relief Liquid - Vicks
  3. Cold And Flu Drugs Market Size, Share, Trends & Forecast - Verified Market Research
  4. Cold and Flu Drugs Market: Industry Analysis and Forecast (2024-2030) - Stellar Market Research
  5. NyQuil - Onlinehome.us - Kristen A. Swanson

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.